Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Cervical Dysplasia Diagnostic Market Forecasts to 2025 - Advancement in Diagnostic Technology & Novel Drug Treatments - Research and Markets

Research and Markets
Posted on: 30 Nov 17

The "Global Cervical Dysplasia Diagnostic Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025" report has been added to Research and Markets' offering.

The global cervical dysplasia diagnostic market was valued at US$ 437.3 Mn in 2016, and is expected to reach US$ 791.3 Mn by 2025, expanding at a CAGR of 6.5% from 2017 to 2025

Annually around 250,000 to 1 million women in the U.S. are diagnosed with cervical dysplasia.

Cervical cancer is a global burden, especially in developing countries where it is the most common cause of preventable cancer-related mortality. Thus rising incidence of cervical dysplasia and advancement in diagnostic technology and treatment option are the key factors contributing the growth of cervical dysplasia diagnostic market.

Key Market Movements:

  • Increase in incidence and mortality of cervical cancer is leading to global burden especially in developing countries. In developed countries government is taking initiatives for screening programs with goal of early diagnosis and treatment of cervical dysplasia which play pivotal role in growth of cervical dysplasia diagnostic market.
  • Advancement in diagnostic technology and novel drug treatment option available in market would further propel the growth of cervical dysplasia diagnostic market.

North America dominates the global cervical dysplasia diagnostic market followed by the Europe. Rise in incidence of cervical dysplasia, advancement in diagnostic technology, awareness about cervical cancer and available novel treatment option are some of the major factors driving the growth of cervical dysplasia diagnostic market in North America and Europe. Asia Pacific is the fastest growing regional market for cervical dysplasia with highest CAGR in the forecast period.

Key Topics Covered:

Chapter 1. Preface

Chapter 2. Executive Summary

Chapter 3. Cervical Dysplasia Diagnostic: Market Dynamics and Future Outlook

Chapter 4. Global Cervical Dysplasia Diagnostic Market, by Type, 2015 - 2025 (US$ Mn)

Chapter 5. Global Cervical Dysplasia Diagnostic Market, by Geography, 2015 - 2025 (US$ Mn)

Chapter 6. Company Profiles

  • Abbott Laboratories
  • Becton, Dickinson and company
  • F. Hoffmann La-Roche Ltd.
  • Hologic, Inc.
  • Micromedic Technologies Ltd.
  • OncoHealth Corporation
  • PDS Biotechnology Corporation
  • Quest Diagnostics, Inc.

For more information about this report visit

View source version on

Business Wire

Last updated on: 30/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.